Aspen Aerogels Inc
NYSE: ASPN · INDUSTRIALS · BUILDING PRODUCTS & EQUIPMENT
Updated 2026-06-05
Aspen Aerogels Inc (ASPN) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2009 | $28.62M | $-18.64M | -12.70% | -54.45% | -65.13% |
| 2010 | $43.21M | $-9.91M | 13.17% | -17.35% | -22.94% |
| 2011 | $45.95M | $-32.83M | -5.71% | -44.76% | -71.45% |
| 2012 | $63.45M | $-56.14M | -12.56% | -51.96% | -88.48% |
| 2013 | $86.09M | $-47.61M | 12.46% | -23.20% | -55.30% |
| 2014 | $102.40M | $-66.32M | 16.68% | -15.67% | -64.77% |
| 2015 | $122.52M | $-6.42M | 20.12% | -5.09% | -5.24% |
| 2016 | $117.74M | $-12.02M | 19.80% | -9.53% | -10.21% |
| 2017 | $111.63M | $-19.32M | 16.73% | -17.14% | -17.31% |
| 2018 | $104.36M | $-34.44M | 12.14% | -32.50% | -33.00% |
| 2019 | $139.38M | $-4.76M | 18.86% | -10.16% | -3.41% |
| 2020 | $100.27M | $-11.85M | 14.55% | -21.51% | -11.82% |
| 2021 | $121.62M | $-27.88M | 8.17% | -33.38% | -22.93% |
| 2022 | $121.62M | $-37.09M | 8.17% | -33.38% | -30.50% |
| 2023 | $238.72M | $-45.81M | 23.84% | -20.61% | -19.19% |
| 2024 | $452.70M | $13.38M | 40.40% | 12.05% | 2.95% |
| 2025 | $271.10M | $-389.55M | 16.97% | -18.96% | -143.69% |
Frequently asked questions
What is Aspen Aerogels Inc's revenue?
Aspen Aerogels Inc's trailing twelve-month revenue is $230.26M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is ASPN?
In its most recent fiscal year, ASPN ran a gross margin of 16.97%, an operating margin of -18.96%, and a net margin of -143.69%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does ASPN generate?
ASPN produced $-4.58M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is ASPN's balance sheet healthy?
ASPN holds $156.86M in cash and equivalents against $79.80M in long-term debt, on $235.52M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.